MAUNA KEA TECHNOLOGIES (FR:ALMKT)

:ALMKT

ALMKT

MAUNA KEA TECHNOLOGIES

RESEARCH TOOLSreports

Want to see FR:ALMKT full AI Analyst Report?

MAUNA KEA TECHNOLOGIES (ALMKT) Price & Analysis

1 Followers

ALMKT Stock Chart & Stats

€0.08

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€0.08

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€0.07 - €0.23

Previous CloseN/A

Volume123.00K

Average Volume (3M)830.17K

Market Cap

€29.51M

Enterprise Value€20.71M

Total Cash (Recent Filing)€4.97M

Total Debt (Recent Filing)€12.08M

Price to Earnings (P/E)2.6

Beta0.84

Next Earnings

Oct 08, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares Outstanding192,097,270

10 Day Avg. Volume1,028,958

30 Day Avg. Volume830,169

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)-2.65

Price to Sales (P/S)1.55

P/FCF Ratio-3.24

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.02

Revenue Forecast (FY)€7.75M

Bulls Say, Bears Say

Bulls Say

High Gross MarginsSustained ~75% gross margins indicate the core CLE platform and probes capture attractive unit economics. If installed base and procedure volumes scale, margin leverage can translate to durable underlying profitability even before fixing operating-cost structure, supporting long-term cash generation potential.

Consumable-driven Recurring Revenue ModelA capital-equipment placement plus single-use probe model creates recurring, procedure-linked revenue and lifetime customer value. This structural mix supports predictable per-procedure revenue, margin sustainability, and opportunities for service contracts and cross-selling as installed base grows over months to years.

Material Debt ReductionSubstantial deleveraging in 2025 reduces near-term refinancing and interest risks and improves financial flexibility. Lower absolute debt improves the company's capacity to allocate cash to operations or R&D and makes future capital raises or lender negotiations less strained over a multi-month horizon.

Bears Say

Persistent Negative Cash FlowConsistent negative OCF and FCF show the business burns cash to run operations and is not self-funding. This persistent cash deficit forces reliance on external financing or balance-sheet actions, constraining investment pace, R&D, and commercial expansion and increasing execution risk over coming quarters.

Deep Operating LossesAn ~-83% operating margin signals structural cost or scale issues: revenue gains have not translated into operating profitability. Until fixed-costs are controlled or volumes rise significantly, operating losses will continue to pressure liquidity and make sustainable profitability unlikely in the medium term.

Negative Shareholders' EquityPersistent negative equity reflects accumulated deficits and weak solvency. It limits financing options, raises covenant and counterparty concerns, and can impair ability to attract strategic partners or larger-scale customers, posing a structural constraint on long-term growth and resilience.

ALMKT FAQ

What was MAUNA KEA TECHNOLOGIES’s price range in the past 12 months?

MAUNA KEA TECHNOLOGIES lowest stock price was €0.07 and its highest was €0.23 in the past 12 months.

What is MAUNA KEA TECHNOLOGIES’s market cap?

MAUNA KEA TECHNOLOGIES’s market cap is €29.51M.

When is MAUNA KEA TECHNOLOGIES’s upcoming earnings report date?

MAUNA KEA TECHNOLOGIES’s upcoming earnings report date is Oct 08, 2026 which is in 109 days.

How were MAUNA KEA TECHNOLOGIES’s earnings last quarter?

MAUNA KEA TECHNOLOGIES released its earnings results on Apr 22, 2026. The company reported €0.19 earnings per share for the quarter, beating the consensus estimate of N/A by €0.19.

Is MAUNA KEA TECHNOLOGIES overvalued?

According to Wall Street analysts MAUNA KEA TECHNOLOGIES’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MAUNA KEA TECHNOLOGIES pay dividends?

MAUNA KEA TECHNOLOGIES does not currently pay dividends.

What is MAUNA KEA TECHNOLOGIES’s EPS estimate?

MAUNA KEA TECHNOLOGIES’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MAUNA KEA TECHNOLOGIES have?

MAUNA KEA TECHNOLOGIES has 192,097,270 shares outstanding.

What happened to MAUNA KEA TECHNOLOGIES’s price movement after its last earnings report?

MAUNA KEA TECHNOLOGIES reported an EPS of €0.19 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.622%.

Which hedge fund is a major shareholder of MAUNA KEA TECHNOLOGIES?

Currently, no hedge funds are holding shares in FR:ALMKT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MAUNA KEA TECHNOLOGIES

Mauna Kea Technologies SA operates as a medical device enterprise, producing and distributing its offerings throughout Europe and worldwide. Its product line serves various medical specialties such as gastroenterology, pulmonology, and urology. Central to its portfolio is Cellvizio, an in vivo cellular imaging platform that delivers real-time data. This innovative system assists medical practitioners in tracking disease evolution, evaluating immediate physiological responses, delineating ambiguous tissue areas, and providing guidance during surgical procedures. Founded in 2000, the company's headquarters are situated in Paris, France.